EA201990086A1 - Применение пробиотиков в лечении и/или профилактике атопического дерматита - Google Patents

Применение пробиотиков в лечении и/или профилактике атопического дерматита

Info

Publication number
EA201990086A1
EA201990086A1 EA201990086A EA201990086A EA201990086A1 EA 201990086 A1 EA201990086 A1 EA 201990086A1 EA 201990086 A EA201990086 A EA 201990086A EA 201990086 A EA201990086 A EA 201990086A EA 201990086 A1 EA201990086 A1 EA 201990086A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
atopic dermatitis
probiotics
application
Prior art date
Application number
EA201990086A
Other languages
English (en)
Inventor
Висент Мануэль Наварро Лопез
Ана Адела Рамирез Боска
Хосе Мануэль Перез Оркуин
Даниэль Рамон Видал
Сальвадор Женовес Мартинез
Мария Эмпар Ченолл Куадрос
Франциско Мануэль Кодонер Кортес
Original Assignee
Бионоу Рисёрч, С.Л.
Коротт, С.Л.
Биополис, С.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56920674&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201990086(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бионоу Рисёрч, С.Л., Коротт, С.Л., Биополис, С.Л. filed Critical Бионоу Рисёрч, С.Л.
Publication of EA201990086A1 publication Critical patent/EA201990086A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Preparation Of Fruits And Vegetables (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

Настоящее изобретение предназначено для использования пробиотической композиции, содержащей Bifidobacterium animalis подв. lactis (B. lactis), Bifidobacterium longum и Lactobacillus casei, конкретно штаммов B. lactis CECT 8145, B. longum CECT 7347 и/или L. casei CECT 9104, в лечении и/или профилактике атопического дерматита.
EA201990086A 2016-07-18 2017-07-18 Применение пробиотиков в лечении и/или профилактике атопического дерматита EA201990086A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382342.0A EP3272396A1 (en) 2016-07-18 2016-07-18 Use of probiotics in the treatment and/or prevention of atopic dermatitis
PCT/EP2017/068131 WO2018015388A1 (en) 2016-07-18 2017-07-18 Use of probiotics in the treatment and/or prevention of atopic dermatitis

Publications (1)

Publication Number Publication Date
EA201990086A1 true EA201990086A1 (ru) 2019-12-30

Family

ID=56920674

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990086A EA201990086A1 (ru) 2016-07-18 2017-07-18 Применение пробиотиков в лечении и/или профилактике атопического дерматита

Country Status (28)

Country Link
US (2) US20190282636A1 (ru)
EP (2) EP3272396A1 (ru)
JP (1) JP6998364B2 (ru)
KR (1) KR102390806B1 (ru)
CN (1) CN110214014A (ru)
AR (1) AR109085A1 (ru)
AU (1) AU2017299137B2 (ru)
BR (1) BR112019001116A2 (ru)
CA (1) CA3031002A1 (ru)
DK (1) DK3484585T3 (ru)
EA (1) EA201990086A1 (ru)
ES (1) ES2863398T3 (ru)
HR (1) HRP20210995T1 (ru)
HU (1) HUE055264T2 (ru)
IL (1) IL264282B1 (ru)
MA (1) MA44893B1 (ru)
MX (1) MX2019000821A (ru)
MY (1) MY194858A (ru)
PE (1) PE20190417A1 (ru)
PH (1) PH12019500123A1 (ru)
PL (1) PL3484585T3 (ru)
PT (1) PT3484585T (ru)
RS (1) RS62079B1 (ru)
RU (1) RU2757453C2 (ru)
SI (1) SI3484585T1 (ru)
UA (1) UA126664C2 (ru)
WO (1) WO2018015388A1 (ru)
ZA (1) ZA201900869B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109652349B (zh) * 2019-02-25 2021-03-02 江南大学 一株能够缓解特应性皮炎的长双歧杆菌及其应用
KR102136346B1 (ko) * 2019-12-23 2020-07-22 주식회사 락토메이슨 한국인 영유아 유래 신규한 비피도박테리움 애니멀리스 락티스 lm1017을 유효성분으로 포함하는, 아토피 피부염의 예방 및 치료용 조성물
EP3851115A1 (en) 2020-01-15 2021-07-21 Biopolis, S.L. Probiotic composition for its use as an antioxidant
CN111296842B (zh) * 2020-02-14 2021-01-05 赵一鸣 一种具有抗敏作用的益生菌组合物
CN111528479A (zh) * 2020-05-15 2020-08-14 深圳爱米基因科技有限责任公司 一种缓解特应性皮炎功能的益生菌和益生元组合物及应用
EP3915537A1 (en) * 2020-05-28 2021-12-01 DuPont Nutrition Biosciences ApS Bifidobacteria for preventing, reducing or treating skin aging
EP3973971A1 (de) * 2020-09-28 2022-03-30 Medice Arzneimittel Pütter GmbH & Co. KG Probiotische pharmazeutische zusammensetzung
CN113430133B (zh) * 2021-06-24 2023-06-23 微康益生菌(苏州)股份有限公司 一种能够缓解溃疡性结肠炎的复合益生菌、制备方法及其应用
WO2023111270A1 (en) * 2021-12-16 2023-06-22 Biopolis, S. L. Use of postbiotics in the treatment and/or prevention of anxiety disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004250337A (ja) * 2003-02-18 2004-09-09 Sunstar Inc アレルギー疾患改善用製剤
JP5112069B2 (ja) 2004-10-04 2013-01-09 ロレアル 敏感肌のための化粧品及び／または皮膚科組成物
CN101165162A (zh) * 2007-09-30 2008-04-23 苏国权 一种益生菌活性制剂
ES2343499B1 (es) * 2007-12-24 2011-06-10 Consejo Superior De Investigaciones Cientificas Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
MX338680B (es) * 2009-05-11 2016-04-27 Nestec Sa Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes.
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP2228067B1 (de) * 2010-02-22 2013-12-11 LR Health & Beauty Systems GmbH Probiotische Zusammensetzung und deren Verwendung
ES2389547B1 (es) * 2010-12-07 2013-08-08 Consejo Superior De Investigaciones Científicas (Csic) Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
KR20130049554A (ko) * 2011-11-04 2013-05-14 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물
ES2526986B1 (es) * 2013-07-18 2015-11-02 Biopolis, S.L. Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
CN104605277A (zh) * 2013-11-05 2015-05-13 熊涛 一种功能性益生菌发酵果蔬粉的制备方法
KR101545551B1 (ko) * 2013-12-12 2015-08-19 주식회사한국야쿠르트 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물
CN103705543A (zh) * 2013-12-25 2014-04-09 广州华农大实验兽药有限公司 一种动物用粪源复方益生菌可溶性粉及其制备方法
KR101724601B1 (ko) * 2014-11-04 2017-04-10 주식회사 쎌바이오텍 아토피 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
HUE055264T2 (hu) 2021-11-29
JP6998364B2 (ja) 2022-01-18
CA3031002A1 (en) 2018-01-25
JP2019521174A (ja) 2019-07-25
EP3272396A1 (en) 2018-01-24
RU2019104462A (ru) 2020-08-18
ES2863398T3 (es) 2021-10-11
AR109085A1 (es) 2018-10-24
IL264282A (en) 2019-02-28
US20190282636A1 (en) 2019-09-19
MA44893B1 (fr) 2021-06-30
SI3484585T1 (sl) 2021-08-31
MX2019000821A (es) 2019-12-16
AU2017299137B2 (en) 2023-03-30
EP3484585B1 (en) 2021-03-24
KR20190042575A (ko) 2019-04-24
IL264282B1 (en) 2024-04-01
HRP20210995T1 (hr) 2021-09-17
PE20190417A1 (es) 2019-03-19
PT3484585T (pt) 2021-06-11
RS62079B1 (sr) 2021-07-30
PH12019500123A1 (en) 2019-04-15
EP3484585A1 (en) 2019-05-22
US20230048705A1 (en) 2023-02-16
RU2757453C2 (ru) 2021-10-15
WO2018015388A1 (en) 2018-01-25
ZA201900869B (en) 2019-12-18
RU2019104462A3 (ru) 2020-08-18
MY194858A (en) 2022-12-20
AU2017299137A1 (en) 2019-02-28
BR112019001116A2 (pt) 2019-04-30
UA126664C2 (uk) 2023-01-11
MA44893A1 (fr) 2019-05-31
DK3484585T3 (da) 2021-06-21
CN110214014A (zh) 2019-09-06
KR102390806B1 (ko) 2022-04-25
PL3484585T3 (pl) 2021-11-22

Similar Documents

Publication Publication Date Title
EA201990086A1 (ru) Применение пробиотиков в лечении и/или профилактике атопического дерматита
PH12018502042A1 (en) Use of probiotics in the treatment and/or prevention of psoriasis
MX2011012069A (es) Micro-organismos no-replicantes y su efecto inmuno estimulador.
PH12018502406A1 (en) Nutritional composition comprising a probiotic for the prevention and/or treatment of anxiety disorders and related conditions in a mammal
DK3554517T3 (da) Probiotisk sammensætning omfattende lactobacillus rhamnosus og lactobacillus paracasei stammer
ZA202105310B (en) Probiotic compositions comprising lactobacillus reuteri strains and methods of use
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
MX2016014991A (es) Composiciones que contienen acido borico y una mezcla de lactobacilos.
EP3544620A4 (en) STABLE PROBIOTIC COMPOSITION CONTAINING BACILLUS COAGULANS MTCC 5856 AND RELATED DETECTION METHOD
MX2017007654A (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas.
HK1198326A1 (zh) 用於預防或治療上呼吸道感染的鼠李糖乳桿菌和動物雙歧桿菌乳亞種
MX2021006185A (es) Combinacion de probioticos para el tratamiento de trastornos alergicos.
MX2017008700A (es) Empleo de probioticos en el incremento de la fertilidad masculina.
AU2019263623A8 (en) Probiotic Bifidobacterium breve strain and compositions comprising said strain
PL397178A1 (pl) Kompozycja probiotyczna
UA120331U (uk) Пробіотик "болмол"
UA127306U (uk) Комплексний пробіотичний препарат
PL406051A1 (pl) Zastosowanie kompozycji probiotycznej
UA105131U (ru) Состав йогурта
RS54225B1 (en) Indigenous LACTOBACILLUS strains and their use as probiotics
EA201200191A1 (ru) КОНСОРЦИУМ БАКТЕРИАЛЬНЫХ КУЛЬТУР ДЛЯ ПРИГОТОВЛЕНИЯ ЙОГУРТА (Streptococcus thermophiles a1, Lactococcus lactis a1-1, Lactobacillus plantarum sh2, Lactobacillus fermentum pl3, Lactobacillus acidophilus k4, Bifidobacterium longum pl5, Bifidobacterium bifidum ki6)
UA89037U (ru) Кормовая добавка с пробиотическим действием "пробиолакт"
UA89242U (ru) Состав йогурта